Showing results (51-60 of 73) with videos related to
Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry|September 17, 2008
Structure-activity study at positions 3 and 4 of human neuropeptide SValeria Camarda, Claudio Trapella, Girolamo Calo', et al.Peptides|May 7, 2005
Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT1 and AT2 receptorsGhassan Bkaily, Nesrine El-Bizri, Moni Nader, et al.Journal of Medicinal Chemistry|January 10, 2008
Synthesis and biological activity of human neuropeptide S analogues modified in position 2Valeria Camarda, Claudio Trapella, Girolamo Calo, et al.European Journal of Pharmacology|May 19, 2009
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24Carmela Fischetti, Valeria Camarda, Anna Rizzi, et al.The Journal of Pharmacology and Experimental Therapeutics|October 31, 2008
In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide SValeria Camarda, Anna Rizzi, Chiara Ruzza, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|June 19, 2002
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studiesRaffaella Bigoni, Daniela Rizzi, Anna Rizzi, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|June 19, 2002
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studiesAnna Rizzi, Maria Bonaria Salis, Roberto Ciccocioppo, et al.Journal of Medicinal Chemistry|December 31, 2008
Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonistsRemo Guerrini, Valeria Camarda, Claudio Trapella, et al.Peptides|May 26, 2009
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptorMadura Batuwangala, Valeria Camarda, John McDonald, et al.Peptides|May 29, 2007
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptorAnna Rizzi, Barbara Spagnolo, Richard D Wainford, et al.Pageof 8